SOUTH PLAINS FINANCIAL, INC. (SPFI)
South Plains Financial declared a quarterly cash dividend of $0.18 per share on outstanding common stock, payable August 10, 2026 to shareholders of record as of July 27, 2026.
View raw filing on EDGAR →Filings Radar
SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Evaxion A/S (EVAX)
This press release announces Evaxion's presentation of three-year clinical efficacy data for its lead cancer vaccine candidate EVX-01 at the ESMO Congress 2026. The disclosure highlights positive trial results (75% ORR, 92% durability at two years, and new stand-alone therapy data) that are material to investors assessing the company's clinical progress and commercial prospects. While not a discrete event like an approval or M&A transaction, the announcement of significant clinical milestone data from an ongoing phase 2 trial is a material operational/clinical development event that would affect a reasonable investor's assessment of the registrant's pipeline and competitive position.
View raw filing on EDGAR →Evogene Ltd. (EVGN)
The 6-K discloses an ongoing shareholder activism campaign initiated by shareholders who filed a Schedule 13D on July 10, 2026, demanding removal of all current board members except the CEO and replacement with activist nominees. While the filing also mentions an increase in an at-the-market offering amount, the substantive disclosure is the risk factors update addressing the material governance threat posed by the activist campaign, including potential proxy contests, board composition changes, and operational disruption. This is a governance event—specifically shareholder activism and potential proxy contest risk—that does not fit the specific categories of exec_departure, exec_appointment, or shareholder_vote_results (no vote has occurred yet), making governance_other the appropriate classification.
View raw filing on EDGAR →QTREX Quantum Ltd. (QTEXW)
The exhibit announces the appointment of Dr. Shlomit Chappel-Ram as an independent director to QTREX's Board, effective July 14, 2026. The disclosure emphasizes her deep technical expertise in AME technology from her prior role as VP of R&D at Nano Dimension (the source of QTREX's recently acquired AME platform), making her appointment material to investors evaluating the company's ability to execute on its quantum connectivity strategy. This is a clear exec_appointment event.
View raw filing on EDGAR →RTB Digital, Inc. (RVYL)
RTB Digital announced a comprehensive technology partnership with Mario Nawfal, a major digital media figure with over 1 billion monthly video views, to host his non-social digital platform (marionawfal.com) on RTB's integrated technology stack. This is a material strategic partnership involving a high-profile media partner and represents a significant operational milestone for the company's enterprise media platform business, but does not fit the specific categories of M&A activity, debt issuance, or other defined event types.
View raw filing on EDGAR →Targa Resources Corp. (TRGP)
The filing discloses the appointment of Thomas Mathiasmeier to the Board of Directors as a Class II Director on July 16, 2026, and his concurrent appointment to the Audit Committee. While the disclosure also mentions compensatory arrangements (a pro-rated restricted stock award of 477 shares), the principal disclosed action is the appointment itself. Mathiasmeier's substantial experience as President of Global Gas, Power & Emerging Markets at ConocoPhillips and his industry expertise make this a material governance event affecting the composition and expertise of the Board.
View raw filing on EDGAR →MakeMyTrip Ltd (MMYT)
MakeMyTrip announced a proposed initial public offering and listing of its wholly-owned subsidiary MMT India on Indian stock exchanges. This constitutes a material capital-structure transaction involving a partial divestiture of equity in a subsidiary while retaining control, with proceeds to strengthen cash position and fund strategic initiatives. The announcement explicitly states the IPO will involve sale of equity shares by MakeMyTrip and ibibo Holdings, and that MMT India will remain a consolidated subsidiary post-IPO.
View raw filing on EDGAR →NovaBridge Biosciences (NBP)
This exhibit is the 2026 Omnibus Share Incentive Plan adopted by the Board on July 13, 2026. It establishes a comprehensive equity compensation framework authorizing grants of options, restricted shares, share units, and cash-based awards to employees, consultants, and directors. The plan document itself—setting forth the terms, conditions, and administration of compensatory arrangements—constitutes a material disclosure of executive and employee compensation arrangements under Item 5.02(e) equivalent disclosure obligations for foreign private issuers.
View raw filing on EDGAR →Sanofi (SNYNF)
This press release announces FDA approval of Sarclisa Escena (isatuximab-irfc) subcutaneous formulation with an on-body injector (CirCLIQ OBI), representing a significant product innovation and regulatory milestone for Sanofi's oncology franchise. The approval expands the delivery options for an existing drug across multiple approved indications in multiple myeloma treatment, supported by the pivotal IRAKLIA phase 3 study demonstrating non-inferiority to IV formulation. While not a discrete M&A, debt, or governance event, this regulatory approval of a novel delivery mechanism for a cornerstone oncology product materially affects the commercial potential and competitive positioning of Sarclisa, which has already been prescribed to over 70,000 patients worldwide.
View raw filing on EDGAR →AUTOLIV INC (ALV)
Autoliv issued a press release on July 17, 2026 announcing its financial results for Q2 2026, including net sales of $2,803 million, operating margin of 6.8%, adjusted operating margin of 9.6%, diluted EPS of $1.35, and full-year 2026 guidance.
View raw filing on EDGAR →Docebo Inc. (DCBO)
The exhibit announces preliminary unaudited Q2 2026 financial results (subscription revenue US$63.5–63.7M, total revenue US$68.3–68.5M, Adjusted EBITDA US$10.9–11.1M) alongside revised Q3 2026 and FY2026 guidance. While the exhibit also discloses a substantial issuer bid (share repurchase), the primary substantive disclosure is the earnings announcement with forward-looking guidance, which is material to investor assessment of financial performance and future prospects.
View raw filing on EDGAR →Kalaris Therapeutics, Inc. (KLRS)
Kalaris disclosed positive Phase 1a clinical trial data for its lead candidate TH103 in neovascular AMD, including expanded cohort results (17 treatment-naïve, 3 treatment-experienced patients) showing improvements in vision (9.2-letter BCVA improvement), retinal anatomy (118µm OCT improvement), extended time-to-retreatment, and favorable pharmacokinetic findings with extended intraocular retention and improved safety profile.
View raw filing on EDGAR →VivoSim Labs, INC. (VIVS)
VivoSim Labs entered into a Securities Purchase Agreement on July 16, 2026, to issue pre-funded warrants and common warrants to purchase up to 4,705,883 shares of common stock at $0.85 per share for approximately $4.0 million in gross proceeds. The unregistered securities are issued under Section 4(a)(2) and Regulation D exemptions, with the company agreeing to file a registration statement for resale. The transaction includes amendment of existing Armistice warrants downward from $9.60 to $0.85 per share, creating substantial warrant overhang and dilution to existing shareholders.
View raw filing on EDGAR →LAGO Evergreen Credit
LAGO Evergreen Credit disclosed an unregistered sale of 666,496 common shares at $25.37 per share for an aggregate purchase price of $16.9 million to accredited investors in a private placement. The transaction is explicitly exempt under Section 4(a)(2) of the Securities Act and Regulation D, which are the standard exemptions for private placements. This is a classic dilutive issuance that would materially affect a reasonable investor's assessment of share ownership and capital structure.
View raw filing on EDGAR →ENNIS, INC. (EBF)
The Board rejected director Michael D. Magill's resignation following his failure to receive majority shareholder support in the uncontested election at the 2026 Annual Meeting, with the Board disputing ISS's independence analysis and emphasizing Magill's qualifications despite the shareholder vote outcome.
View raw filing on EDGAR →Organon & Co. (OGN)
The filing discloses material litigation filed on July 6, 2026, in New Jersey Superior Court challenging the Merger on grounds of materially incomplete and misleading proxy disclosures. The plaintiff seeks injunctive relief to enjoin the stockholder vote scheduled for July 23, 2026, and a motion for preliminary injunction was filed on July 13, 2026. This litigation directly threatens the timing and completion of a material M&A transaction and would affect a reasonable investor's assessment of deal risk.
View raw filing on EDGAR →ARS Pharmaceuticals, Inc. (SPRY)
The filing discloses two executive departures: Richard Lowenthal's resignation from the Board of Directors effective immediately on July 15, 2026, and Sarina Tanimoto, M.D. (Chief Medical Officer), ceasing employment under a termination without cause on the same date. While severance and compensatory arrangements are mentioned, the principal disclosed action centers on these two individuals leaving their roles. The departure of a CMO is material to a pharmaceutical company's operations and investor assessment.
View raw filing on EDGAR →EyePoint, Inc. (EYPT)
EyePoint settled potential False Claims Act and related civil violations with the DOJ, OIG-HHS, and DHA involving alleged improper sales and marketing practices for DEXYCU® from 2019–2023. The settlement requires payment of $4.68 million plus interest and attorneys' fees, and imposes a five-year Corporate Integrity Agreement with significant compliance obligations. This is a material government settlement resolving regulatory and civil liability exposure.
View raw filing on EDGAR →Bain Capital Private Credit
The Company entered into a Fourth Amendment to its credit facility, increasing the total facility amount from $650 million to $750 million and expanding the accordion provision from $800 million to $1 billion maximum, representing a material expansion of the Company's direct financial obligations and borrowing capacity.
View raw filing on EDGAR →Four Leaf Acquisition Corp
Four Leaf Acquisition Corp terminated its material Business Combination Agreement with XYDD, effective July 15, 2026, due to regulatory review under PRC law. The company is now pursuing an alternative business combination with Data443.
View raw filing on EDGAR →Four Leaf Acquisition Corp
Data443 agreed to issue a US$2,000,000 promissory note to XYDD as compensation for terminating the business combination agreement, with 15% per annum interest if unpaid and a conversion feature into equity representing up to 19.99% of post-combination shares.
View raw filing on EDGAR →Ohmyhome Ltd (OMH)
The 6-K discloses entry into a Securities Purchase Agreement on July 17, 2026, for a private placement of 5,333,331 Class A ordinary shares and 5,333,331 warrants to non-U.S. persons at $0.30 per share/warrant, generating approximately $1.6 million in gross proceeds. This is a classic dilutive equity issuance under Regulation S, material to investors as it increases share count and dilutes existing shareholders' ownership.
View raw filing on EDGAR →Maase Inc. (MAAS)
MAAS announced entry into an agreement to sell its entire 49% equity interest in Laixi Intelligent for US$17 million in cash. This is a material asset disposition and divestiture of a non-core business unit (unmanned car wash). While the transaction is framed as a strategic portfolio optimization to refocus on AI, it represents a significant financial event involving the sale of a subsidiary stake. The event does not fit the specific `ma_activity` category (which typically covers acquisitions, mergers, or changes of control) but is clearly a material financial transaction involving the disposition of an equity interest, making `financial_other` the most appropriate classification.
View raw filing on EDGAR →Huadi International Group Co., Ltd. (HUDI)
The press release discloses receipt of a Nasdaq Listing Qualifications Staff Determination Letter on July 14, 2026, notifying the Company that it failed to maintain the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The Company has been granted a 180-calendar-day compliance period (until January 11, 2027) to regain compliance, with potential for an additional 180-day period if certain conditions are met. This is a material delisting risk disclosure under Nasdaq Listing Rule 5810(b), which requires prompt disclosure of deficiency notifications.
View raw filing on EDGAR →Raphael Pharmaceutical Inc. (RAPH)
The filing discloses two significant executive departures: Ajay Kumar Dhadha resigned as Chairman and Director effective June 30, 2026, and Guy Ofir resigned as Chief Financial Officer, General Counsel, and Director effective July 16, 2026. While the section also mentions the appointment of Uri Tadelis as CFO, the principal disclosed actions center on the departures of two senior officers, including the CFO and Board Chairman. Both resignations are stated to be voluntary and without disagreement with the Company.
View raw filing on EDGAR →Thunder Power Holdings, Inc. (AIEV)
Thunder Power Holdings reincorporated from Delaware to Nevada on June 23, 2026, with stockholders holding approximately 62% of voting power approving the change by written consent on May 26, 2026. The reincorporation resulted in material modifications to certain stockholder rights due to differences between Delaware and Nevada law, though the company's board, management, business, operations, and third-party contracts remained unchanged.
View raw filing on EDGAR →Aditxt, Inc. (ADTX)
Aditxt entered into Amendment No. 2 to a Note Purchase Agreement on July 16, 2026, allowing a new investor to join and issuing two Additional Notes as senior secured debt instruments backed by substantially all assets of its subsidiary Ignite and pledged equity.
View raw filing on EDGAR →Optimus Healthcare Services, Inc.
The filing discloses the Board's decision to initiate an orderly wind down of the Company's operations, including a reduction in force and maintenance of only a core group of employees necessary for the wind down. While the filing is captioned Item 2.05 (Costs Associated with Exit or Disposal Activities), the primary disclosed action is the operational restructuring and workforce reduction in connection with the Company's decision to cease operations, with all Directors and Officers resigning effective August 5, 2026. This constitutes a material workforce reduction and operational restructuring event.
View raw filing on EDGAR →HIGHWAY HOLDINGS LTD (HIHO)
This is a press release disclosing Highway Holdings' fiscal fourth quarter and full-year 2026 financial results (year ended March 31, 2026), including net sales, gross profit, net loss per share, and consolidated financial statements. The disclosure is material as it reports significant deterioration: full-year net sales declined 35% to $4.8M, the company swung from net income of $106K to a net loss of $1.5M, and recorded a $125K impairment charge due to adverse business conditions and Myanmar political unrest. These results would materially affect a reasonable investor's assessment of the registrant's financial condition and performance.
View raw filing on EDGAR →CO2 Energy Transition Corp. (NOEMR)
CO2 Energy Transition Corp., a SPAC, announced entry into a non-binding letter of intent for an initial business combination with a Texas-based oil and gas company focused on lithium and strontium recovery. The press release explicitly states the parties "intend to negotiate and enter into definitive agreements for the proposed business combination" with a target execution date of September 16, 2026. This constitutes material M&A activity under Item 1.01, as it represents the SPAC's pursuit of its stated purpose and would result in a change of control or significant business combination.
View raw filing on EDGAR →Archimedes Tech SPAC Partners III Co. (ARCIW)
The filing discloses the appointment of Stephen N. Cannon as a Class II director of Archimedes Tech SPAC Partners III Co., effective July 13, 2026, with concurrent appointment to the audit, compensation, and nominating committees. The disclosure centers on the principal action of a person taking a board role, making this an exec_appointment event. The appointment is material as it involves a director with extensive SPAC experience joining the board of a blank-check company.
View raw filing on EDGAR →Agencia Comercial Spirits Ltd. (AGCC)
The press release announces entry into three material agreements for a strategic expansion into AI computing infrastructure in Indonesia: a construction contract (US$40–50 million), network equipment procurement (US$10.1 million), and a five-year maintenance agreement (US$1.0 million fixed). While these are not customer revenue contracts, they represent a significant capital commitment and strategic pivot beyond the company's historical whisky business. This is an operational/strategic business event—a material contract and partnership milestone—that does not fit the specific event types (M&A, debt issuance, workforce reduction, etc.) but clearly warrants disclosure as a material operational initiative.
View raw filing on EDGAR →SB FINANCIAL GROUP, INC. (SBFG)
The filing discloses a quarterly cash dividend declaration of $0.16 per common share, payable August 28, 2026 to shareholders of record as of August 14, 2026. The press release explicitly states this represents a 7% increase over the prior year dividend of $0.15 per share and notes a 2.3% yield. This is a routine but material shareholder distribution event that would affect investor assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →Huachen AI Parking Management Technology Holding Co., Ltd (HCAI)
The 6-K discloses a private placement of 7,000,000 Class A ordinary shares at US$1.552 per share for a total of US$10,864,000, completed on July 17, 2026. The shares were issued pursuant to Section 4(a)(2) of the Securities Act and Regulation D/S, which are classic exemptions for unregistered equity issuances. This is a material dilutive equity offering that would affect a reasonable investor's assessment of ownership and capital structure.
View raw filing on EDGAR →SAGTEC GLOBAL Ltd (SAGT)
The 6-K discloses settlement of material litigation: Helena Global Investment Opportunities I Ltd. filed a complaint in New York Supreme Court arising from a July 2025 purchase agreement. Sagtec settled on March 20, 2026, agreeing to pay $250,000 in two tranches, with the action discontinued on April 13, 2026. The settlement amount and formal resolution of a contractual dispute constitute a material litigation event requiring disclosure.
View raw filing on EDGAR →QVC INC (QVCDQ)
QVC Inc. filed voluntary Chapter 11 bankruptcy petitions on April 16, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. This Item 7.01 disclosure furnishes the company's monthly operating report for May 2026 and a press release announcing confirmation of the company's prepackaged restructuring plan by the Bankruptcy Court on July 15, 2026. The filing is a terminal event materially threatening the registrant's continued existence as an independent operating entity.
View raw filing on EDGAR →REGIONS FINANCIAL CORP (RF-PF)
Regions Financial Corporation issued a press release on July 17, 2026 announcing preliminary results of operations for the quarter ended June 30, 2026, disclosing net income of $549 million and diluted EPS of $0.64 (adjusted diluted EPS of $0.68), with a live webcast and presentation materials provided for investor review.
View raw filing on EDGAR →QVC Group, Inc. (QVCGQ)
QVC Group, Inc. filed voluntary Chapter 11 petitions on April 16, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. This Item 7.01 disclosure furnishes the company's monthly operating report for May 2026 and a press release announcing confirmation of the company's prepackaged financial restructuring plan. The filing explicitly references the Chapter 11 Cases and the Bankruptcy Court's confirmation ruling, making this a terminal bankruptcy event that is material to any reasonable investor assessing the registrant's continued existence.
View raw filing on EDGAR →BASSETT FURNITURE INDUSTRIES INC (BSET)
The filing discloses a declaration of a regular quarterly dividend of $0.20 per share of common stock payable on August 28, 2026, to shareholders of record on August 14, 2026. This is a straightforward dividend distribution event. While routine for established companies, dividend declarations are material to shareholders as they represent a return of capital and signal management's confidence in cash flow.
View raw filing on EDGAR →STEELE BANCORP INC (STLE)
Steele Bancorp issued a press release on July 17, 2026 titled "Steele Bancorp, Inc. Reports Second Quarter 2026 Earnings" disclosing unaudited quarterly and year-to-date financial results for the period ended June 30, 2026. The filing includes detailed consolidated balance sheets, statements of income, and key financial metrics (net income of $5.26M for Q2 2026 vs. $1.82M in Q2 2025; EPS of $1.54 vs. $0.98). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →Click Holdings Ltd. (CLIK)
This press release announces a significant operational milestone (6 million cumulative senior care hours delivered) and unveils a global expansion strategy with specific targets (HK$500 million revenue within three years, 15 million care hours by 2028). While the disclosure emphasizes ESG metrics and social impact, the core substance is a strategic business announcement regarding market expansion into Mainland China and overseas markets using proprietary workforce technologies. This is an operational/strategic milestone rather than a discrete financial event (earnings release), M&A activity, or governance matter, making operational_other the most appropriate classification.
View raw filing on EDGAR →Cocrystal Pharma, Inc. (COCP)
The filing discloses results of the 2026 Annual Meeting of Stockholders held on July 14, 2026, including voting outcomes on three proposals: election of five board directors (Proposal 1), ratification of Weinberg & Company as independent auditor (Proposal 2), and adjournment authority (Proposal 3). This is a classic Item 5.07 shareholder vote results disclosure with detailed vote tallies for each nominee and proposal.
View raw filing on EDGAR →Brand Engagement Network Inc. (BNAIW)
The filing discloses the appointment of Christian Unterseer to the Board of Directors effective July 1, 2026, in connection with the Cataneo acquisition. The principal disclosed action is a person taking a role (board director), and the disclosure includes his background as founder of the acquired company and equity compensation arrangements. This is a material executive appointment tied to a material acquisition.
View raw filing on EDGAR →NextTrip, Inc. (NTRP)
The filing discloses the appointment of Casey D'Ambra as President of Media, an executive officer position, effective July 13, 2026. Item 5.02(c) explicitly covers election of directors and appointment of officers. The disclosure includes her compensation structure ($205,000 base salary plus up to $50,000 bonus in restricted shares), severance terms, and background. This is a material executive appointment that would affect investor assessment of company leadership.
View raw filing on EDGAR →GrowHub Ltd (TGHL)
GrowHub Ltd has scheduled extraordinary general meetings for 5 August 2026 to seek shareholder approval for material governance and capital structure changes, including adoption of amended memorandum and articles of association, a significant increase in authorized share capital from US$50,000 to US$2,525,000, and authorization for a reverse share split up to 1:200 ratio.
View raw filing on EDGAR →Calisa Acquisition Corp (ALISU)
The filing discloses a material operational and strategic development by GoodVision AI, which has entered into a Business Combination Agreement with Calisa Acquisition Corp (the registrant). The press release announces GoodVision's establishment of its first AI Factory in Japan with a strategic partnership with AI Storm, including a phased expansion roadmap targeting 100 MW capacity within three years. While the primary focus is on GoodVision's operational milestone, the filing is furnished under Item 7.01 (Regulation FD Disclosure) in connection with the pending business combination between the two entities. The disclosure is material to investors evaluating the proposed merger, as it demonstrates GoodVision's strategic execution and market expansion plans that would directly impact the combined company's future performance and value.
View raw filing on EDGAR →Polomar Health Services, Inc. (PMHS)
The filing discloses a change in the registrant's independent accountant under Item 4.01. On July 8, 2026, the Audit Committee dismissed GreenGrowth CPAs and appointed Haskell & White LLP as the new independent registered public accounting firm. The prior auditor's reports contained no adverse opinions, disclaimers, or qualifications, and there were no disagreements or reportable events, indicating a routine auditor transition. This is material to investors as it affects the audit oversight and financial reporting assurance for the company.
View raw filing on EDGAR →CaliberCos Inc. (CWD)
CaliberCos announced groundbreaking on its first Hyatt Studios extended-stay hotel in Steamboat Springs, Colorado, marking the start of construction on a 114-room property expected to open in H2 2027. This is a material operational and strategic milestone for the company's hospitality development platform—the first of three Hyatt Studios projects to begin construction under a Master Development Agreement. While the event is clearly operational and strategic in nature (a major development milestone), it does not fit neatly into any specific named category (e.g., it is not an M&A transaction, a material impairment, or a workforce action), making `operational_other` the most appropriate classification.
View raw filing on EDGAR →ECARX Holdings Inc. (ECXWW)
This Amendment Deed modifies the terms of convertible senior notes totaling US$100 million (US$35M initial + US$65M additional notes) issued by ECARX Holdings Inc. to multiple investors including SPDB, CNCB, ICBCI, and others. The document amends and restates the Note Conditions across all outstanding convertible notes and the underlying Note Purchase Agreement. While this is technically an amendment to existing debt rather than a new issuance, it materially modifies the direct financial obligations and terms governing US$100 million in convertible debt, which is a material financial event affecting the registrant's capital structure and investor rights.
View raw filing on EDGAR →ECARX Holdings Inc. (ECXWW)
The 6-K discloses execution of definitive agreements for ECARX's acquisition of the Flyme software business portfolio for RMB 1.8 billion on June 18, 2026, with expected full acquisition of intellectual property rights related to Flyme OS and Flyme Auto. This is a material acquisition of a significant software asset that expands the company's product portfolio and IP holdings. The announcement also highlights operational milestones (143,000 new deployments in June, 3.148 million cumulative vehicles) demonstrating the strategic importance of this acquisition to the company's growth trajectory.
View raw filing on EDGAR →